Seagen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Seagen and buy or sell other stocks, options, and ETFs commission-free!

About SGEN

Seattle Genetics is a clinical-stage biotechnology company that focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in the pivotal trial for patients with relapsed or refractory Hodgkin lymphoma. 

CEO
David R. Epstein, MBA
CEODavid R. Epstein, MBA
Employees
Employees
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
1997
Founded1997
Employees
Employees

SGEN Key Statistics

Market cap
43.15B
Market cap43.15B
Price-Earnings ratio
-57.10
Price-Earnings ratio-57.10
Dividend yield
Dividend yield
Average volume
3.45M
Average volume3.45M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$228.96
52 Week high$228.96
52 Week low
$123.77
52 Week low$123.77
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.